PMC:7283670 / 49145-49391 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T143","span":{"begin":172,"end":181},"obj":"Chemical"},{"id":"T144","span":{"begin":202,"end":213},"obj":"Chemical"}],"attributes":[{"id":"A143","pred":"chebi_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A144","pred":"chebi_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"}],"text":"utive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical s"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T542","span":{"begin":109,"end":117},"obj":"Sentence"},{"id":"T543","span":{"begin":118,"end":147},"obj":"Sentence"},{"id":"T544","span":{"begin":148,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"utive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical s"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T185","span":{"begin":93,"end":98},"obj":"Phenotype"},{"id":"T186","span":{"begin":102,"end":107},"obj":"Phenotype"}],"attributes":[{"id":"A185","pred":"hp_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A186","pred":"hp_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/HP_0012735"}],"text":"utive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical s"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1383","span":{"begin":93,"end":98},"obj":"Disease"},{"id":"1384","span":{"begin":102,"end":107},"obj":"Disease"}],"attributes":[{"id":"A1383","pred":"tao:has_database_id","subj":"1383","obj":"MESH:D005334"},{"id":"A1384","pred":"tao:has_database_id","subj":"1384","obj":"MESH:D003371"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"utive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical s"}